Onset of Mild Cognitive Impairment in Parkinson Disease

Alzheimer Disease and Associated Disorders

Volumn 30, Issue 2, 2016, Pages 127-133

  Johnson, David K ^a,b   Langford, Zachary ^a   Garnier Villarreal, Mauricio ^a   Morris, John C ^a   Galvin, James E ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer disease; Bayes theorem; longitudinal; Parkinson disease with dementia; Parkinson disease Parkinsonism; piecewise regression

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT;

AGED; ARTICLE; BAYES THEOREM; BRADYKINESIA; BRADYPHRENIA; CLINICAL ARTICLE; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DEMENTIA; DEPTH PERCEPTION; DISEASE COURSE; EPISODIC MEMORY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; PAIRED ASSOCIATE LEARNING; PARKINSON DISEASE; PRIORITY JOURNAL; SEMANTIC MEMORY; WECHSLER ADULT INTELLIGENCE SCALE; WORKING MEMORY; COGNITIVE DEFECT; DISEASE EXACERBATION; NEUROPSYCHOLOGICAL TEST; PHYSIOLOGY; PSYCHOLOGY; SHORT TERM MEMORY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGED; COGNITIVE DYSFUNCTION; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MODELS, STATISTICAL; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE;

EID: 84973098817     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/WAD.0000000000000088     Document Type: Article

References (40)

1. Galvin JE. Cognitive change in Parkinson disease. Alzheimer Dis Assoc Disord. 2006;20:302-310.
2. Galvin JE, Pollack J, Morris JC. Clinical phenotype of Parkinson disease dementia. Neurology. 2006;67:1605-1611.
3. Muslimovic D, Schmand B, Speelman JD, et al. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc. 2007;13:920-932.
4. Muslimovic D, Post B, Speelman JD, et al. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc. 2009;15:426-437.
5. Reid WG, Hely MA, Morris JG, et al. Dementia in Parkinson's disease: a 20-year neuropsychological study (Sydney Multicentre Study). J Neurol Neurosurg Psychiatry. 2011;82:1033-1037.
6. Johnson DK, Galvin JE. Longitudinal changes in cognition deficits in Parkinson's disease with and without dementia. Dement Geriatr Cogn Disord. 2011;31:98-108.
7. Broeders M, de Bie RM, Velseboer DC, et al. Evolution of mild cognitive impairment in Parkinson disease. Neurology. 2013;81:346-352.
8. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 2007;68:812-819.
9. Dubois B. Is PD-MCI a useful concept? Mov Disord. 2007;22:1215-1216.
10. Emre M, Aarsland D, Brown R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord. 2007;22:1689-1707; quiz 1837.
11. Litvan I, Goldman JG, Troster AI, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012;27: 349-356.
12. Geurtsen GJ, Hoogland J, Goldman JG, et al. Parkinson's disease mild cognitive impairment: application and validation of the criteria. J Parkinsons Dis. 2014;4(2):131-7. doi: 10.3233/ JPD-130304. 2014;4:131-137.
13. Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58:1985-1992.
14. Price JL, Ko AI, Wade MJ, et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. Arch Neurol. 2001;58:1395-1402.
15. Cholerton BA, Zabetian CP, Wan JY, et al. Evaluation of mild cognitive impairment subtypes in Parkinson's disease. Mov Disord. 2014;29:756-764.
16. Biundo R, Weis L, Facchini S, et al. Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord. 2014;20:394-399.
17. Goldman JG, Holden S, Bernard B, et al. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease. Mov Disord. 2013;28: 1972-1979.
18. Johnson DK, Storandt M, Morris JC, et al. Longitudinal study of the transition from healthy aging to Alzheimer disease. Arch Neurol. 2009;66:1254-1259.
19. Johnson DK, Storandt M, Morris JC, et al. Cognitive profiles in dementia: Alzheimer disease vs nondemented aging. Neurology. 2008;71:1783-1789.
20. Slate EH, Turnbull BW. Statistical models for longitudinal biomarkers of disease onset. Stat Med. 2000;19:617-637.
21. Goldman WP, Baty JD, Buckles VD, et al. Cognitive and motor functioning in Parkinson disease: subjects with and without questionable dementia. Arch Neurol. 1998;55:674-680.
22. Hughes AJ, Ben-Shlomo Y, Daniel SE, et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992;42:1142-1146.
23. Morris JC. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology. 1993;43:2412b-2414b.
24. Botwinick J, Storandt M. Speed functions, vocabulary ability, and age. Percept Mot Skills. 1973;36:1123-1128.
25. Wechsler D. Adminstration and Scoring Manual: Wechsler Adult Intelligence Scale. San Antonio, TX: Harcourt Brace; 1997.
26. Benton AL. The Revised Visual Retention Test: Clinical and Experimental Applications. New York: Psychological Corporation; 1963.
27. Thurstone LL, Thurstone LG. Examiner Manual for the SRA Primary Mental Abilities Test. Chicago: Science Research Associates; 1949.
28. Wechsler D. Administration and Scoring Manual: Wechsler Memory Scale. San Antonio, TX: Harcourt Brace; 1997.
29. Goodglass H, Kaplan E. Boston Naming Test Scoring Booklet. Philadelphia: Lea & Febiger; 1983.
30. Cudeck R, Klebe KJ. Multiphase mixed-effects models for repeated measures data. Psychol Methods. 2002;7:41-63.
31. Wang LJ, McArdle JJ. A simulation study comparison of Bayesian estimation with conventional methods for estimating unknown change points. Struct Eqn Model. 2008;15:52-74.
32. Duncombe ME, Bradshaw JL, Iansek R, et al. Parkinsonian patients without dementia or depression do not suffer from bradyphrenia as indexed by performance in mental rotation tasks with and without advance information. Neuropsychologia. 1994;32:1383-1396.
33. Pate DS, Margolin DI. Cognitive slowing in Parkinson's and Alzheimer's patients: distinguishing bradyphrenia from dementia. Neurology. 1994;44:669-674.
34. Barton BR, Bernard B, Czernecki V, et al. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing. Mov Disord. 2014;29: 1252-1257.
35. Jack CR, Knopman DS, Jagust WJ, et al. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119-128.
36. Troncoso JC, Cataldo M, Nixon RA, et al. Neuropathology of preclinical and clinical late-onset Alzheimer's disease. Ann Neurol. 1998;43:673-676.
37. Marinelli L, Crupi D, Di Rocco A, et al. Learning and consolidation of visuo-motor adaptation in Parkinson's disease. Parkinsonism Relat Disord. 2009;15:6-11.
38. Marinelli L, Perfetti B, Moisello C, et al. Increased reaction time predicts visual learning deficits in Parkinson's disease. Mov Disord. 2010;25:1498-1501.
39. Stewart T, Liu C, Ginghina C, et al. Cerebrospinal fluid alphasynuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort. Am J Pathol. 2014;184: 966-975.
40. Yarnall AJ, Breen DP, Duncan GW, et al. Characterizing mild cognitive impairment in incident Parkinson disease: the ICICLE-PD study. Neurology. 2014;82:308-316.